Does NATALIZUMAB Cause Infusion site swelling? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Infusion site swelling have been filed in association with NATALIZUMAB (TYRUKO). This represents 0.0% of all adverse event reports for NATALIZUMAB.
19
Reports of Infusion site swelling with NATALIZUMAB
0.0%
of all NATALIZUMAB reports
0
Deaths
2
Hospitalizations
How Dangerous Is Infusion site swelling From NATALIZUMAB?
Of the 19 reports, 2 (10.5%) required hospitalization.
Is Infusion site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB Cause?
Multiple sclerosis relapse (6,478)
Fatigue (4,456)
Multiple sclerosis (4,078)
Memory impairment (3,024)
Malaise (2,523)
Fall (2,481)
Headache (2,476)
Gait disturbance (2,427)
Prescribed underdose (2,162)
Maternal exposure during pregnancy (1,948)
What Other Drugs Cause Infusion site swelling?
HUMAN IMMUNOGLOBULIN G (1,772)
TREPROSTINIL (1,686)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (241)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (194)
AMBRISENTAN (173)
INFLIXIMAB-DYYB (100)
INFLIXIMAB (98)
MACITENTAN (96)
VEDOLIZUMAB (57)
FOSCARBIDOPA\FOSLEVODOPA (55)
Which NATALIZUMAB Alternatives Have Lower Infusion site swelling Risk?
NATALIZUMAB vs NATALIZUMAB-SZTN
NATALIZUMAB vs NATAMYCIN
NATALIZUMAB vs NATEGLINIDE
NATALIZUMAB vs NAVITOCLAX
NATALIZUMAB vs NAXITAMAB-GQGK